Ferriprotoporphyrin IX dimer (FePPIX dimer)

The Ferriprotoporphyrin IX dimer, often denoted as FePPIX dimer, is a key intermediate in the malaria parasite Plasmodium falciparum's detoxification of heme released from digested hemoglobin during its intraerythrocytic lifecycle stage. Inside the parasite's food vacuole, free ferriprotoporphyrin IX (FP) monomers dimerize via iron(III)-propionate bonds or form μ-oxo/π-π dimers, ultimately crystallizing into haemozoin (malarial pigment) or its synthetic analog β-haematin to prevent toxic buildup.[1][2][3] This dimerization process is essential for parasite survival, as unbound FP acts as a potent lytic toxin with detergent-like effects on biological membranes.[2] In malaria, antimalarial drugs like chloroquine target this pathway by binding FP tightly, inhibiting dimerization and sequestration into haemozoin, leading to accumulation of toxic chloroquine-FP complexes that kill the parasite.[2][4] Speciation of FP dimers depends on pH, solvent, concentration, and salts, with μ-oxo dimers favored in aprotic solvents and π-π dimers in protic ones.[3][5] While primarily relevant to malaria infection, the target's role highlights heme metabolism as a validated drug target, though challenges include resistance mechanisms like altered FP handling in parasites.[2][4] Computational and spectroscopic studies confirm the dimer's structural features, including Fe-carboxylate bridging, aiding antimalarial design efforts.[1][3]

Other names

FP dimerμ-oxo dimer of ferriprotoporphyrin IXπ-π dimer of ferriprotoporphyrin IXHaemozoin dimer unitβ-haematin dimer

Inhibits dimerization and polymerization to haemozoin/β-haematin; Forms toxic drug-FP complexes that disrupt parasite membranes; Induces μ-oxo dimer formation (chloroquine); Enhances FP accumulation in membranes for lysis.